[1]
N. Ilić and K. Atkinson, “Manufacturing and use of human placenta-derived mesenchymal stromal cells for phase I clinical trials: Establishment and evaluation of a protocol”, Vojnosanit Pregl, vol. 71, no. 7, Jun. 2014, doi: 10.2298/3730.